Information  X 
Enter a valid email address

Huntsworth PLC (HNT)

  Print      Mail a friend       Annual reports

Thursday 14 December, 2017

Huntsworth PLC

Trading Update

RNS Number : 2932Z
Huntsworth PLC
14 December 2017
 

 

           

Trading update

 

Huntsworth plc, the healthcare communications and public relations group, today issues a trading update for the 11 months to 30 November 2017.

 

 

Trading

 

The Group continues to trade well and expects to reach at least market consensus* headline profit estimates for the year to 31 December 2017. This has been led by continuing strong growth at Huntsworth Health particularly in Evoke and Apothecom which now account for over 65% of Huntsworth Health revenue and profit. The Creative Engagement Group, which Huntsworth purchased in July 2017, has performed well, is now fully integrated within the Group and is increasingly engaged in joint new business with other Group agencies.

 

 

Financial Position

 

The Group remains in a strong financial position, operating well within its £75m facility. Net debt at 30 November 2017 was approximately £44m, equating to less than 1.5x net debt to pro forma EBITDA**.

 

 

Outlook

 

The Group is confident about future trading and expects continued good growth prospects in its Healthcare businesses. It remains focused on driving improved operating profit throughout the Group.

 

*Consensus Headline PBT is £22.8m

**Pro forma EBITDA takes into account the full annualisation of M&A in 2017.

 

 

 Enquiries



Citigate Dewe Rogerson

020 7638 9571

Angharad Couch

Nick Reading

Elizabeth Kittle


 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGGWAPUPMGMW

a d v e r t i s e m e n t